Effects of linalyl acetate on oxidative stress, inflammation and endothelial dysfunction: can linalyl acetate prevent

You Kyoung Shin1, Geun Hee Seol1,2

  • 1Department of Basic Nursing Science, College of Nursing, Korea University, Seoul, Republic of Korea.

PubMed

Insights

Linalyl acetate (LA), found in lavender and clary sage, shows potential for preventing mild cognitive impairment (MCI). Its antioxidant and anti-inflammatory properties may counteract key factors contributing to MCI development.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Natural Products

Background:

  • Mild cognitive impairment (MCI) is a growing public health concern with unclear underlying mechanisms.
  • MCI is linked to oxidative stress, inflammation, and endothelial dysfunction.
  • Current treatments for MCI lack approved agents, and cholinesterase inhibitors show uncertain efficacy.

Purpose of the Study:

  • To review the pathogenesis of MCI related to oxidative stress, inflammation, and endothelial dysfunction.
  • To summarize the potential benefits of linalyl acetate (LA) in preventing MCI.
  • To highlight LA as a potential natural product for MCI prevention.

Main Methods:

  • Literature search of PubMed and Google Scholar databases.
  • Review of studies on MCI pathogenesis.
  • Analysis of pharmacological effects of linalyl acetate (LA).

Main Results:

  • Linalyl acetate (LA), a component of clary sage and lavender oils, exhibits neuroprotective, anti-inflammatory, and antioxidant properties.
  • These properties suggest LA may counteract factors contributing to MCI.
  • LA's potential benefits align with addressing oxidative stress, inflammation, and endothelial dysfunction.

Conclusions:

  • Linalyl acetate (LA) shows promise as a natural agent for preventing MCI.
  • Further clinical research is warranted to develop new MCI prevention strategies.
  • High-risk populations with oxidative stress, inflammation, and endothelial dysfunction may benefit from LA-based interventions.

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
155
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
628
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
86
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K